“SAFETY SIGNALS FOR HYPERKALEMIA IN TYPE 2 DIABETES: A FOCUSED REVIEW OF SGLT-2, GLP-1, AND DPP-4 DRUG CLASSES” (2025) Journal of Medical & Health Sciences Review, 2(3), pp. 3711–3716. doi:10.62019/sw57nf20.